Professor Peter John Browett

BMedSci, MBChB, FRACP, FRCPA

Selected publications and creative works (Research Outputs)

  • van Kan, M., Burns, K. E., Browett, P., & Helsby, N. A. (2019). A higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells. Scientific Reports, 910.1038/s41598-019-55161-3
    Other University of Auckland co-authors: Maia van Kan, Katie Burns, Nuala Helsby
  • Desai, R., Taghavi, S., Chase, J. C., Chopra, M., Chien, J., Browett, P. J., ... Bohlander, S. K. (2019). Unexpected variation in leukemia stem cell frequency and genetic heterogeneity in two murine leukemia models initiated by AML1/ETO9a and CALM/AF10. Leukemia10.1038/s41375-019-0657-8
    Other University of Auckland co-authors: Rhea Desai, Stefan Bohlander, Purvi Kakadiya
  • Molloy, B., Marty Francisco, M., Ellison Misoo, C., Rabitsch, W., Itaelae-Remes, M., Dominietto, A., ... Leavitt Randi, Y. (2019). RISK FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CLINICALLY SIGNIFICANT CYTOMEGALOVIRUS (CMV) INFECTION IN ALLOGENEIC PROGENITOR TRANSPLANTATION. Paper presented at 61st National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy, Valencia, SPAIN. 24 October - 26 October 2019. HAEMATOLOGICA. (pp. 1).
  • Risitano, A., Kulasekararaj, A., Lee, J. W., Notaro, R., Brodsky, R. A., Huang, M., ... Browett, P. (2019). A PHASE 2 OPEN-LABEL PROOF OF CONCEPT STUDY OF THE ORAL, SMALL MOLECULE FACTOR D INHIBITOR, ACH-4471, IN UNTREATED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH). Paper presented at 47th Congress of the Italian-Society-of-Hematology, Rome, ITALY. 7 October - 9 October 2019. HAEMATOLOGICA. (pp. 1).
  • Das, A. B., Kakadia, P. M., Wojcik, D., Pemberton, L., Browett, P. J., Bohlander, S. K., & Vissers, M. C. M. (2019). Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1. Blood cancer journal, 9 (10)10.1038/s41408-019-0242-4
    URL: http://hdl.handle.net/2292/49612
    Other University of Auckland co-authors: Purvi Kakadiya, Stefan Bohlander
  • Chin, J., Gane, E., Browett, P., & Van De Water, N. (2019). Graft-versus-host disease after liver transplantation: A diagnostic challenge. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. (pp. 2).
  • Marty, F. M., Ellison, M. C., Rabitsch, W., Itala-Remes, M., Dominietto, A., Peggs, K., ... Joshi, A. (2019). Risk factors associated with the development of clinically significant cytomegalovirus (CMV) infection in the allogeneic hematopoietic-cell transplant (HCT) letermovir prophylaxis trial. Paper presented at 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, GERMANY. 24 March - 27 March 2019. BONE MARROW TRANSPLANTATION. (pp. 2).
  • Chien, N., Petrasich, M., Chan, G., Theakston, E., Ruskova, A., Eaddy, N., ... Browett, P. J. (2019). Early treatment of acute promyelocytic leukaemia is accurately guided by the PML protein localisation pattern: real-life experience from a tertiary New Zealand centre. Pathology, 51 (4), 412-420. 10.1016/j.pathol.2019.01.003
    Other University of Auckland co-authors: Maggie Kalev

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 4, Room 403
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand